T regulatory cells and TH17 cells in peri-silicone implant capsular fibrosis

Plastic and Reconstructive Surgery

Volumn 129, Issue 2, 2012, Pages

  Wolfram, Dolores ^a,b   Rabensteiner, Evelyn ^a,b   Grundtman, Cecilia ^a,b   Böck, Günther ^a,b   Mayerl, Christina ^a,b   Parson, Walther ^a,b   Almanzar, Giovanni ^a,b   Hasenöhrl, Carlo ^a,b   Piza Katzer, Hildegunde ^a,b   Wick, Georg ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Excellentbeauty   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE GEL; SODIUM CHLORIDE;

ADULT; ARTICLE; BREAST; BREAST ENDOPROSTHESIS; FEMALE; FIBROSIS; HUMAN; IMMUNOLOGY; IMPLANT CAPSULAR CONTRACTURE; MIDDLE AGED; PATHOLOGY; REGULATORY T LYMPHOCYTE; TH17 CELL;

ADULT; BREAST; BREAST IMPLANTS; FEMALE; FIBROSIS; HUMANS; IMPLANT CAPSULAR CONTRACTURE; MIDDLE AGED; SILICONE GELS; SODIUM CHLORIDE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; YOUNG ADULT;

EID: 84856764491     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31823aeacf     Document Type: Article

References (43)

1. Appleton BE, Lee P. The development of systemic-sclerosis (scleroderma) following augmentation mammaplasty. J Rheumatol. 1993;20:1052-1054.
2. Brody GS. On the safety of breast implants. Plast Reconstr Surg. 1997;100:1314-1321.
3. Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol. 2001;28:996-1003.
4. Henriksen TF, Holmich LR, Fryzek JP, et al. Incidence and severity of short-term complications after breast augmentation: Results from a nationwide breast implant registry. Ann Plast Surg. 2003;51:531-539.
5. Alfano C, Mazzocchi M, Scuderi N. Mammary compliance: An objective measurement of capsular contracture. Aesthetic Plast Surg. 2004;28:75-79.
6. Fisher JC. The silicone controversy: When will science prevail? N Engl J Med. 1992;326:1696-1698.
7. Gerszten PC. A formal risk assessment of silicone breast implants. Biomaterials 1999;20:1063-1069.
8. Gylbert L, Asplund O, Jurell G. Capsular contracture after breast reconstruction with silicone-gel and saline-filled implants: A 6-year follow-up. Plast Reconstr Surg. 1990;85:373-377.
9. Handel N, Cordray T, Gutierrez J, Jensen JA. A long-term study of outcomes, complications, and patient satisfaction with breast implants. Plast Reconstr Surg. 2006;117:757-767.
10. Henriksen TF, Fryzek JP, Holmich LR, et al. Surgical intervention and capsular contracture after breast augmentation: A prospective study of risk factors. Ann Plast Surg. 2005;54: 343-351.
11. Backovic A, Huang HL, Del Frari B, Piza H, Huber LA, Wick G. Identification and dynamics of proteins adhering to the surface of medical silicones in vivo and in vitro. J Proteome Res. 2007;6:376-381.
12. Wolfram D, Rainer C, Niederegger H, Piza H, Wick G. Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmun. 2004;23:81-91; erratum 2005;24:361.
13. Shanklin DR, Smalley DL. The immunopathology of siliconosis: History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone. Immunol Res. 1998;18:125-173.
14. Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4(+)CD25(+) T cells. Clin Immunol. 2005;115:10-18.
15. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001;193:1285-1294.
16. Pfoertner S, Jeron A, Probst-Kepper M, et al. Signatures of human regulatory T cells: An encounter with old friends and new players. Genome Biol. 2006;7:R54.
17. Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 2009; 127:196-205.
18. Thornton AM, Shevach EM. CD4(+)CD25(+) immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188: 287-296.
19. Venigalla RK, Tretter T, Krienke S, et al. Reduced CD4α,CD25-T cell sensitivity to the suppressive function of CD4α,CD25(high), CD127(-/low) regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 2008;58:2120-2130.
20. Wilczynski JR, Radwan M, Kalinka J. The characterization and role of regulatory T cells in immune reactions. Front Biosci. 2008;13:2266-2274.
21. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: Function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2010;159:109-119.
22. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008;29:44-56.
23. Yoo ZB, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: A novel cytokine derived from T cells. J Immunol. 1995;155:5483-5486.
24. Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and regulatory T cells. J Clin Immunol. 2008; 28:660-670.
25. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485-517.
26. Erdman SE, Rao VP, Olipitz W, et al. Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer 2010;126:1651-1665.
27. Passos ST, Silver JS, O'Hara AC, Sehy D, Stumhofer JS, Hunter CA. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol. 2010;184:1776-1783.
28. Baker JL. Augmentation mammaplasty: A comparative analysis (comment). Plast Reconstr Surg. 1999;103:1763-1765.
29. Herndler-Brandstetter D, Schwaiger S, Veel E, et al. CD25-expressing CD8(+) T cells are potent memory cells in old age. J Immunol. 2005;175:1566-1574.
30. Lo Re S, Dumoutier L, Couillin I, et al. IL-17A-producing gammadelta T and TH17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol. 2010;184:6367-6377.
31. Simonian PL, Roark CL, Born WK, O'Brien RL, Fontenot AP. Gammadelta T cells and TH17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl Res. 2009;154:222-227.
32. Kotsianidis I, Nakou E, Bouchliou I, et al. Global impairment of CD4+CD25+Foxp3+regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:1121-1130.
33. Sasaki M, Ikeda H, Sawada S, Sato Y, Nakanuma Y. Naturallyoccuring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis. J Clin Pathol. 2007;60:1102-1107.
34. O'Connor RA, Taams LS, Anderton SM. Translational minireview series on Th17 Cells: CD4+T helper cells: Functional plasticity and differential sensitivity to regulatory T cell-mediated regulation. Clin Exp Immunol. 2010;159:137-147.
35. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007; 204:1849-1861.
36. EvansHG,Suddason T, Jackson I, Taams LS, LordGM.Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci USA. 2007;104:17034-17039.
37. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med. 2006;203:2785-2791.
38. Stummvoll GH, DiPaolo RJ, Huter EN, et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol. 2008;181:1908-1916.
39. Bettelli E, Oukka M, Kuchroo VK. TH17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345-350.
40. Deknuydt F, Bioley G, Valmori D, Ayyoub M. IL-1 beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol. 2009;131:298-307.
41. Koenen HJ, SmeetsRLVink PM, van Rijssen E, BootsAM,Joosten I. Human CD25(high)Foxp3(pos) regulatory T cells differentiate into IL-17-producing cells. Blood 2008;112:2340-2352.
42. Radhakrishnan S, Cabrera R, Schenk EL, et al. Retraction: Reprogrammed FoxP3(+) T regulatory cells become IL-17(+) antigen-specific autoimmune effectors in vitro and in vivo. J Immunol. 2010;184:6556.
43. Tamboto H, Vickery K, Deva AK. Subclinical (biofilm) infection causes capsular contracture in a porcine model following augmentation mammaplasty. Plast Reconstr Surg. 2010; 126:835-842.